Pancreatic cancer
Conditions
Interventions
AI-ROSE group:Artificial intelligence based Rapid On-Site Cytopathological Evaluationon
Human-ROSE group:Human Based Rapid On-Site Cytopathological Evaluationon
Sponsors
The Affiliated Drum Tower Hospital of Nanjing University Medical School
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Age >= 18 years; 2. Ultrasound/CT/MRI suggestive of solid pancreatic occupancy requiring EUS-FNA to clarify the nature; EUS clearly confirmed and lesions >1 cm in diameter in the long axis and lesions with a predominantly solid component in EUS images (solid echogenicity/cystic echogenicity >60%, i.e. in solid occupancy, some lesions may have cystic echogenicity in ultrasound images due to the presence of necrotic liquefaction); 3. Sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patient has abnormal coagulation (platelet count 1.5); 2. Recent oral anticoagulant medication; 3. The presence of vessels in the puncture route or the presence of a puncture that is too far away or a history of GI diversion surgery that is not expected to complete the EUS-FNA operation; 4. Inability to tolerate anesthesia.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Accuracy;Sensitivity;Specificity;Positive predictive value;Negative predictive value; | — |
Secondary
| Measure | Time frame |
|---|---|
| Sample satisfaction;Puncture times;Operation time; | — |
Countries
China
Contacts
Public ContactLyu Ying
The Affiliated Drum Tower Hospital of Nanjing University Medical School
Outcome results
None listed